Listed pharmas’ operating profit ratio dropped in KOSPI, but increased in KOSDAQ
Last year, the KOSPI listed pharmaceutical companies’ average operating profit ratio was significantly decreased, but the one of KOSDAQ listed pharmaceutical companies was increased by more than 10%.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of 37 KOSPI and 30 KOSDAQ liste...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
